(NASDAQ: LNTH) Lantheus Holdings's forecast annual revenue growth rate of 10.31% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 6.43%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.31%.
Lantheus Holdings's revenue in 2024 is $1,438,011,000.On average, 6 Wall Street analysts forecast LNTH's revenue for 2024 to be $105,838,751,483, with the lowest LNTH revenue forecast at $105,290,179,980, and the highest LNTH revenue forecast at $106,499,661,764. On average, 5 Wall Street analysts forecast LNTH's revenue for 2025 to be $117,807,552,704, with the lowest LNTH revenue forecast at $111,193,173,163, and the highest LNTH revenue forecast at $126,231,850,220.
In 2026, LNTH is forecast to generate $134,876,798,317 in revenue, with the lowest revenue forecast at $125,694,457,051 and the highest revenue forecast at $160,613,904,139.